Research
- Research Funded to Date
- Research Funded by State
- Research Approach
- Application Details
- Researcher Profiles
- Scientific Advisory Board
Where we have funded research
Since its founding in 2001, LUNGevity has funded 92 research projects at 54 institutions in 23 states focusing on early detection as well as more effective treatments of lung cancer.
California
Beckman Research Institute at the City of Hope
William Bennett
DNA Methylation Changes in Peripheral Blood Monomuclear Cells as Biomarkers of Lung Cancer
Stanford University
Viswam
Nair
In-vivo
and in-vitro Diagnostics to Improve Lung Cancer Care
UCLA
Jane Yanagawa
The Role of Snail in the Regulation of the Invasive Phenotype in NSCLC
UCLA David Geffen School of Medicine
Steven Dubinett and Kostyantyn Krysan
Combined Protein and miRNA Profiles for the Early Detection of Lung Cancer
UCLA David Geffen School of Medicine
Lee Goodglick
In Vitro and In Vivo Characterization of Estrogen Pathway Stimulation in Human Lung Cancer
UCLA David Geffen School of Medicine
Kostyantyn Krysan
Modulation of PGE2-Dependent EGFR Inhibitor Resistance in NCSLC by E-cadherin
University of California, Davis
Oliver Fiehn, Karen Kelly and Suzanne Miyamoto
A system biology approach to biomarkers for early detection of lung cancer
University of Southern California
Nouri Neamati
Preclinical Development of SC21 in Lung Cancer
Veterans Medical Research Foundation
Randolph Hastings
Hormonal Therapy for
Non-Small Cell Carcinoma
Colorado
University of Colorado Denver, AMC and DC
Wilbur Franklin, Kavita Garg and York Miller
Biomarkers to Improve Clinical Assessment of Indeterminate Lung Nodules
Connecticut
Yale University
Lynne Regan
Development of a Novel Class of Therapeutics for Bronchioloalveolar Carcinoma
Florida
H. Lee Moffitt Cancer Center & Research Institute
Eric Haura
Targeting SRC and Stat3 Signaling in EGFR-Driven NSCLC
Mayo Clinic Jacksonville
Alan Fields
A Novel Small Molecule Inhibitor of Protein Kinase C Iota for the Treatment of Lung Cancer
Georgia
Emory University School of Medicine
Johann Brandes
Targeting CHFR through PARP-inhibition: A novel strategy to overcome taxane resistance in adenocarcinomas of the lung
Emory University School of Medicine
Johann Brandes
CHFR methylation as novel predictor for chemotherapy response in NSCLC
Emory University School of Medicine
Shouwei Han
Signaling through PPARy in lung cancer: Potential therapeutic role of PPARy ligands
Illinois
LOGiC (Lung Oncology Group in Chicago)
Correlative study of the effects of agents used in conjunction with targeted therapies in the treatment of lung cancer
Northwestern University
Dwight Seferos
Photo-controllable Carriers for the Rapid Delivery of Anticancer Therapies
Northwestern University Feinberg School of Medicine
Navdeep Chandel
Notch signaling regulates lung cancer
Rush University Medical Center
Jeffrey Borgia
Autoantibody-based biomarkers to aid in the early diagnosis of lung cancer
Rush University Medical Center
Jeffrey Borgia
Molecular signatures to predict response in neoadjuvant chemoradiation therapy of Stage III NSCLC patients
Rush University Medical Center
Jeffrey Borgia
Diagnostic Test Development for NSCLC-Staging of Diagnosed Lung Cancer
Rush University Medical Center
Jeffrey Borgia
Diagnostic Test Development for NSCLC-Early Detection of Lung Cancer
University of Chicago
Patrick Ma
Functional expression of c-Met, its mutations and targeted therapy in lung adenocarcinoma
University of Chicago
Ravi Salgia
Studies and Therapeutic Targeting of Heat Shock Proteins in Lung Cancer
University of Chicago
Federico Innocenti
Molecular signatures of angiogenesis in NSCLC and their prognostic role
University of Illinois at Chicago College of Medicine
Sojin Shikano
Identification of molecules regulating tumorigenic KCNK9 potassium channel
Kansas
University of Kansas Medical Center
Chao Huang and Sitta Sittampalam
Developing Novel Biomarkers and Targets to Address Small Cell Lung Cancer
University of Kansas Medical Center
George Vielhauer
Novel C-terminal Hsp90I with isoform selectivity will function as selective anti-cancer agents in the treatment of lung cancers
Kentucky
University of Louisville JG Brown Cancer Center
John Eaton
A Broad Spectrum Lung Cancer Stem Cell Vaccine
University of Louisville School of Medicine
Carolyn Klinge
Estrogen Receptor Beta Interacting Proteins in Lung Adenocarcinoma
Massachusetts
Boston University
Jennifer
Beane
Biomarkers
of Pre-malignant Disease Progression for Lung Cancer Detection
Brigham and Women's Hospital
Onkar Khullar
Prevention of Nodal Metastasis in Lung Cancer via Lymphatic Trafficking of Paclitaxel-Loaded Expansile Nanoparticles
Children's Hospital Boston
Carla Kim
Isolation and characterization of bronchioloalveolar carcinoma stem cells
Dana-Farber Cancer Institute
Matthew Meyerson
EGFR Pathway Alterations in Human Lung Adenocarcinoma
Massachusetts General Hospital
Rebecca Heist and Anthony Iafrate
Identifying Tumor Genomic Changes in Lung Cancers
Massachusetts General Hospital
Jeffrey Settleman and Sreenath Sharma
Preventing acquired resistance to geftinib and erlotinib in NSCLC
Massachusetts General Hospital
Sreenath Sharma
Chemo-sensitizing NSCLCs to Geftinib/Iressa & Erlotinib/Tarceva
Maryland
Johns Hopkins University School of Medicine
Edward Gabrielson
Examining LKB1 status as a biomarker for response of lung cancer in metform
Johns Hopkins University School of Medicine
Erik Tryggestad
A Probabilistic Approach to High-Dose Lung IGRT
St. Joseph Medical Center Cancer Institute
Mark Krasna
Survivorship: Improving the recognition and treatment of psychosocial distress in lung cancer patients
Michigan
University of Michigan
Douglas Arenberg
Profiling the phenotype of tumor derived stromal fibroblasts
University of Michigan
Venkateshwar Keshamouni
Regulation of Tumor Progression in Peroxisome Proliferator-Activated Recepto-gamma in NSCLC
University of Michigan
Mats Ljungman
Regulation of Myc and microRNA in small cell lung cancer
University of Michigan
Steven Zielske
Enzyme-Prodrug Gene Therapy of Cancer using Mesenchymal Stem Cells
Wayne State University
Michael Tainsky
Autoantibody biomarkers for the detection of lung cancer
Wayne State University, Karmanos Cancer Institute
Michelle Cote
Hormonal factors and lung cancer: A potential target for therapy
Minnesota
Mayo Clinic
Nicholas Vlahakis
The Role of alpha9beta1 Integrin in Modulating Pulmonary Angiogenesis
Mayo Clinic Cancer Center
Dennis Wigle
Surgery versus SBRT for patients with lung cancer and limited pulmonary function
Mayo Graduate School of Medicine
Clinton Doerr
Fluorescence in Situ Hybridization for the Detection of Lung Cancer
University of Minnesota
Timothy Starr
Transposon Mutagenesis for Lung Cancer Gene Discovery
Missouri
Washington University
Alexander Krupnick
The Basis for Immunological Therapy of NSCLC
Washington University
Christopher
Maher
Molecular Predictors of Outcome in Non-small Cell Lung Cancer
New Hampshire
Dartmouth University Medical School
David Robbins
Uncovering Molecular Markers of Hedgehog Antagonist Sensitive Lung Cancer
Dartmouth-Hitchcock Medical Center
William Petty
Targeted Combination Therapy for Lung Cancer Carcinogenesis
New Jersey
Rutgers University
Tamara Minko
Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multi-drug Resistance and Antiapoptotic Cellular Defenses
New York
Albert Einstein College of Medicine
Hayley McDaid
Mechanisms of RAS and RAF-mediated regulation of cap-dependent translation in NSCLC
Columbia University
Charles Powell
Molecular Signatures of Invasiveness in Lung Adenocarcinoma
Columbia University Medical Center
May-Lin Wilgus
Chromosome 7q copy number and lung adenocarcinoma invasion
Memorial Sloan-Kettering Cancer Center
Prasad Adusumilli
Targeted Immunotherapy for Early Stage Lung Cancer
Memorial Sloan-Kettering Cancer Center
Alexei Bogolioubov
The Occurrence of Lung Cancer after Surgical Resection: Impact of New Staging System, Use of Adjuvant Chemotherapy and Value of Chest CT Versus Chest Radiograph
Memorial Sloan-Kettering Cancer Center
William Pao
Mutational Analysis of the Tyrosine Kinase in Lung Cancer
New York University School of Medicine
Patricia Gonzalez Santamaria
Unveiling the role of Ubiquitin Ligases in the Biology and Prognosis of Lung Cancer
NYU School of Medicine
Jessica Scott Donington
Functional Heterogeneity of Osteopontin Isoforms in Lung Cancer
State University of New York at Buffalo
Sai Yendamuri
MiRNA expression profiling to predict recurrence after resection of stage 1 NSCLC
State University of New York at Buffalo
Sai Yendamuri
A microRNA profile to predict recurrence after surgical resection of stage 1 non-smll cell lung cancer
SUNY Upstate Medical University
Jing An
Development of new radiosensitizers for human lung cancers
North Carolina
Duke University
Mark Onaitis
Analysis of Lung Adenocarcinoma Heterogeneity Based upon Cell-of-Origin
Duke University Medical Center
Michael Campa, James Herndon and Edward Patz
Serum Biomarkers for the Early Detection of Lung Cancer
Durham VA Medical Center Pulmonary Service
Scott Shofer
Heterogeneity of Microarray-based Lung Cancer Signature in Patiens with Lung Cancer
University of North Carolina at Chapel Hill
Pilar Blancafort
Discovery of novel artificial transcription factors regulating lung cancer cell invasion and progression
University of North Carolina at Chapel Hill, Lineberger Cancer Center
Albert Baldwin
Targeting NF-KappaB as a new treatment for lung cancer
Ohio
Cleveland Clinic Foundation
Peter Mazzone
Identification and validation of exhaled breath biomarkers for the detection of early stage lung cancer
Ohio State University
Wenrui Duan
Treatment of Spontaneous NSCLC in Transgenic Mice with PRIMA-1, a Novel Anti Cancer Agent
Ohio State University Medical Center
Serge Patrick Nana-Sinkam
Circulating miRNA as a Biomarker in Lung Cancer
Pennsylvania
Lankenau Institute for Medical Research
George Prendergast
Genetic regulation and therapeutic correction of immune escape in lung cancer
Thomas Jefferson University
Michael Lisanti
Role of CAV-1 in Suppressing Lung Tumor Formation: Therapeutic Implications
University of Pennsylvania
Alexander Whitehead
Folate-related biomarkers as predictors of response to pemetrexed therapy
Tennessee
University of Tennessee
Hildegard Schuller
Estrogen enhances the carcinogenic effects of the nicotine derivative NNK
Vanderbilt University
William Pao
Identifying
Tumor Genomic Changes in Lung Cancers
Vanderbilt University Medical Center
David Carbone
Biomarkers for personalizing adjuvant therapy in NSCLC - increasing cures
Vanderbilt University Medical Center
David Carbone
Predictive blood-based markers of response to VeGF Inhibitors in NSCLC
Vanderbilt University Medical Center
Thao Dang
Targeting Gamma-Secretase and the Notch Pathway in Lung Cancer
Vanderbilt University Medical Center
Mohamed
Hassanein
Developing New Non-invasive Methods for the Diagnosis of Lung Cancer
Texas
University of Texas MD Anderson Cancer Center
Lauren
Byers
PARP1 as a Novel Therapeutic Target in Small Cell Lung Cancer
University of Texas MD Anderson Cancer Center
John Heymach
Predictive blood-based markers of response to VeGF Inhibitors in NSCLC
University of Texas MD Anderson Cancer Center
John Heymach
EGFR/estrogen interactions: role in bronchioloalveolar carcinoma and gender differences in the efficacy of antioangiogenic therapy
University of Texas MD Anderson Cancer Center
Seyed Moghaddam
Inflammation-Related Lung Cancer Prevention by Targeting the NF-kB Pathway
University of Texas MD Anderson Cancer Center
Ignacio Wistuba
Biomarkers for personalizing adjuvant therapy in NSCLC - increasing cures
UT Southwestern Medical Center
John Minna
Biomarkers for personalizing adjuvant therapy in NSCLC - increasing cures
Virginia
University of Virginia
George Verghese
Regulation of NSCLC Invasion by Membrane Serine Proteinases and Antiproteinases
Washington
Fred Hutchinson Cancer Research Center
Gary Goodman, Samir Hanash and Christopher Li
Blood Tests for the Early Detection of Lung Cancer
University of Washington School of Medicine
Christopher Slatore
The Association between Incident Lung Cancer and Hormone Replacement Therapy in a Large Cohort
